Application, efficiency and cargo-dependence of transport peptides

International Congress Series

Volumn 1277, Issue , 2005, Pages 95-107

  Langedijk, J P M ^a   Olijhoek, T ^a   Meloen, R H ^a  

^a Pepscan Systems   (Netherlands)

Author keywords

Erns; Protein transduction; PTD; Tat; Transport peptide

Indexed keywords

EID: 33646438599     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.ics.2005.02.016     Document Type: Article

References (18)

1. M. Lindgren, et al., Cell-penetrating peptides 21 (3) (2000) 99-1003.
2. Futaki S., et al. Structural variety of membrane permeable peptides. Current Protein and Peptide Science 4 2 (2003) 87-96
3. Asoh S., et al. Protection against ischemic brain injury by protein therapeutics. Proceedings of the National Academy of Sciences of the United States of America 99 26 (2002) 17107-17112
4. E. Vives, P. Brodin, B. Lebleu, A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus 272 (25) (1997) 16010-16017.
5. Langedijk J.P. Translocation activity of C-terminal domain of pestivirus erns and ribotoxin L3 loop. Journal of Biological Chemistry 277 7 (2002) 5308-5314
6. M. Belting, Heparan sulfate proteoglycan as a plasma membrane carrier 28 (3) (2003) 145-151.
7. Lundberg M., and Johansson M. Positively charged DNA-binding proteins cause apparent cell membrane translocation. Biochemical and Biophysical Research Communication 291 2 (2002) 367-371
8. Langedijk J.P., et al. New transport peptides broaden the horizon of applications for peptidic pharmaceuticals. Molecular Diversity 8 2 (2004) 101-111
9. Park C.B., et al. Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II. PNAS 97 15 (2000) 8245-8250
10. Richard J.P., et al. Cell-penetrating peptides-a reevaluation of the mechanism of cellular uptake. Journal of Biological Chemistry 278 1 (2003) 585-590
11. Rothbard J.B., et al. Role of membrane potential and hydrogen bonding in the mechanism of translocation of guanidinium-rich peptides into cells. Journal of the American Chemical Society 126 31 (2004) 9506-9507
12. R. Fischer, et al., A quantitative validation of fluorophore-labelled cell-permeable peptide conjugates: fluorophore and cargo dependence of import 1564 (2) (2002) 365-374.
13. M. Hallbrink, et al., Cargo delivery kinetics of cell-penetrating peptides 1515 (2) (2001) 101-109.
14. G. Drin, et al., Physico-chemical requirements for cellular uptake of pAntp peptide: role of lipid-binding affinity 268 (5) (2001) 1304-1314.
15. S. Futaki, et al., Translocation of branched-chain arginine peptides through cell membranes: flexibility in the fpatial disposition of positive charges in membrane-permeable peptides 41 (25) (2002) 7925-7930.
16. Wright L.R., Rothbar J.B., and Wender P.A. Guanidinium rich peptide transporters and drug delivery. Current Protein and Peptide Science 4 2 (2003) 105-124
17. Wender P.A., et al. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proceedings of the National Academy of Sciences of the United States of America 97 24 (2000) 13003-13008
18. Rothbard J.B., et al. Arginine-rich molecular transporters for drug delivery: role of backbone spacing in cellular uptake. Journal of Medicinal Chemistry 45 17 (2002) 3612-3618